1. Home
  2. CARM vs NWGL Comparison

CARM vs NWGL Comparison

Compare CARM & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • NWGL
  • Stock Information
  • Founded
  • CARM 2016
  • NWGL 2008
  • Country
  • CARM United States
  • NWGL Macau
  • Employees
  • CARM N/A
  • NWGL N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • NWGL
  • Sector
  • CARM Health Care
  • NWGL
  • Exchange
  • CARM Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • CARM 17.4M
  • NWGL 19.9M
  • IPO Year
  • CARM N/A
  • NWGL 2023
  • Fundamental
  • Price
  • CARM $0.44
  • NWGL $1.30
  • Analyst Decision
  • CARM Hold
  • NWGL
  • Analyst Count
  • CARM 5
  • NWGL 0
  • Target Price
  • CARM $4.57
  • NWGL N/A
  • AVG Volume (30 Days)
  • CARM 277.1K
  • NWGL 8.5K
  • Earning Date
  • CARM 11-07-2024
  • NWGL 11-29-2024
  • Dividend Yield
  • CARM N/A
  • NWGL N/A
  • EPS Growth
  • CARM N/A
  • NWGL N/A
  • EPS
  • CARM N/A
  • NWGL N/A
  • Revenue
  • CARM $20,268,000.00
  • NWGL $21,707,613.00
  • Revenue This Year
  • CARM $46.34
  • NWGL N/A
  • Revenue Next Year
  • CARM N/A
  • NWGL N/A
  • P/E Ratio
  • CARM N/A
  • NWGL N/A
  • Revenue Growth
  • CARM 41.13
  • NWGL N/A
  • 52 Week Low
  • CARM $0.38
  • NWGL $1.04
  • 52 Week High
  • CARM $2.77
  • NWGL $21.97
  • Technical
  • Relative Strength Index (RSI)
  • CARM 37.99
  • NWGL 54.56
  • Support Level
  • CARM $0.42
  • NWGL $1.09
  • Resistance Level
  • CARM $0.48
  • NWGL $1.35
  • Average True Range (ATR)
  • CARM 0.06
  • NWGL 0.08
  • MACD
  • CARM 0.01
  • NWGL 0.02
  • Stochastic Oscillator
  • CARM 18.67
  • NWGL 82.26

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: